The INGENIOUS trial: Impact of pharmacogenetic testing on adverse events in a pragmatic clinical trial
Michael T. Eadon, Marc B. Rosenman, Pengyue Zhang, Cathy R. Fulton, John T. Callaghan, Ann Holmes, Kenneth D. Levy, Samir K. Gupta, David M. Haas, Raj Vuppalanchi, Eric A. Benson, Rolf P. Kreutz, Emma M. Tillman, Tyler Shugg, Rebecca C. Pierson, Brandon T. Gufford, Victoria M. Pratt, Yong Zang, Zeruesenay Desta, Paul Dexter, Todd C. Skaar
Topics & Concepts
MedicinePharmacogeneticsAdverse effectRandomized controlled trialOdds ratioMedical prescriptionCommon Terminology Criteria for Adverse EventsIntensive care medicineInternal medicineEmergency medicinePharmacologyBiochemistryChemistryGenotypeGenePharmaceutical studies and practicesPharmacogenetics and Drug MetabolismHealth Systems, Economic Evaluations, Quality of Life